Med. Univ. Vienna, Dept. Internal Med. I
Vienna, State of Vienna, A1090, Austria
NCT Number: NCT00861432
Tumor patients receiving conventional tumor therapies are included into this study. The patients are randomized into two groups receiving either additive homeopathic therapy or not. Two questionnaires referring to subjective feeling and life quality are filled out by the patients with each visit to the outpatients Department. One of them is the QLQC30 questionnaire of the EORTC. The results of the questionnaires of the two groups are compared.
Looking for future studies?
Notify MeQuality of life is an important issue for cancer patients, especially during the periods of chemotherapy and radiation. Preliminary results have revealed positive effects of add-on homeopathy on quality of life as well as subjective well-being. Patients are receiving classical homeopathy with administration of either globules and/or dilutions. With each appointment, patients complete two questionnaires.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Tumor patients between 18 and 100 years old
Exclusion criteria
Patients younger than 18 years, patients having completed less than 3 questionnaires.
These patients receive additive homeopathic treatment
Other names: homeopathic remedies according to the Pharmacopoeia
Time frame: 3 months
Medical University of Vienna
Other
Evaluation of Quality of Life of Tumor Patients With and Without Additive Homeopathy.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04944550
Neoplasms, Nephroureterectomy
Nîmes, Gard, France
View Trial DetailsNCT02285296
Neoplasms, Oncologic Disorders
Lille, France
View Trial DetailsNCT03229837
Malignancy, Neoplasms
Memphis, Tennessee, United States
View Trial DetailsNCT04266041
Behavior, Brain Diseases
Lebanon, New Hampshire, United States
View Trial Details